Correlation Between Celldex Therapeutics and Amicus Therapeutics

Can any of the company-specific risk be diversified away by investing in both Celldex Therapeutics and Amicus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Celldex Therapeutics and Amicus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Celldex Therapeutics and Amicus Therapeutics, you can compare the effects of market volatilities on Celldex Therapeutics and Amicus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Celldex Therapeutics with a short position of Amicus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Celldex Therapeutics and Amicus Therapeutics.

Diversification Opportunities for Celldex Therapeutics and Amicus Therapeutics

0.51

Correlation Coefficient

Celldex Therapeutics  Amicus Therapeutics

Very weak diversification

The 3 months correlation between Celldex and Amicus is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Celldex Therapeutics and Amicus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amicus Therapeutics and Celldex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Celldex Therapeutics are associated (or correlated) with Amicus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amicus Therapeutics has no effect on the direction of Celldex Therapeutics i.e., Celldex Therapeutics and Amicus Therapeutics go up and down completely randomly.

Pair Corralation between Celldex Therapeutics and Amicus Therapeutics

Given the investment horizon of 90 days Celldex Therapeutics is expected to under-perform the Amicus Therapeutics. In addition to that, Celldex Therapeutics is 1.36 times more volatile than Amicus Therapeutics. It trades about -0.16 of its total potential returns per unit of risk. Amicus Therapeutics is currently generating about -0.03 per unit of volatility. If you would invest  996.00  in Amicus Therapeutics on December 2, 2024 and sell it today you would lose (47.00) from holding Amicus Therapeutics or give up 4.72% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Celldex Therapeutics  vs.  Amicus Therapeutics

Celldex Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Celldex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Amicus Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Amicus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound essential indicators, Amicus Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Celldex Therapeutics and Amicus Therapeutics

The main advantage of trading using opposite Celldex Therapeutics and Amicus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Celldex Therapeutics position performs unexpectedly, Amicus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amicus Therapeutics will offset losses from the drop in Amicus Therapeutics' long position.

The idea behind Celldex Therapeutics and Amicus Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.